Tech
Trial of deep brain stimulation for depression begins
Don’t call it a comeback.
Don’t call it a comeback.
Mood may meet its match with AI.
If you know anyone with schizophrenia, prediabetes, or low bone density, the FDA is on the ball.
Symptoms like fatigue and loss of smell and taste are more common among younger patients, according to Northwestern Medicine.
It’s not just psychiatrists. We also need more psychologists, counselors, therapists, and support staff.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.